Lineage Cell Therapeutics, Inc. — All Filings
1,000 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-K405
10-K405/A
10-Q
10-Q/A
10KSB
10QSB
144
25-NSE
3
3/A
4
4/A
424B1
424B3
424B5
425
5
5/A
8-A12B
8-A12G
8-K
8-K/A
ARS
AW
CERTNYS
CORRESP
CT ORDER
D
D/A
DEF 14A
DEFA14A
DEFR14A
DEL AM
DFAN14A
EFFECT
NT 10-K
NT 10-Q
POS AM
PRE 14A
PRER14A
REGDEX
RW
S-2
S-2/A
S-3
S-3/A
S-4
S-4/A
S-8
S-8 POS
SC 13D
SC 13D/A
SC 13G
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 8-K | 8-K | 0000950170-25-036278 | Mar 10, 2025 | — |
| 4 | 4 | 0000950170-25-018887 | Feb 12, 2025 | Feb 11, 2025 |
| 4 | 4 | 0000950170-25-018897 | Feb 12, 2025 | Feb 11, 2025 |
| SCHEDULE 13G/A | — | 0002012383-25-001485 | Feb 5, 2025 | — |
| 4 | — | 0000919574-25-000555 | Jan 28, 2025 | Jan 27, 2025 |
| SCHEDULE 13D/A | — | 0000919574-25-000556 | Jan 28, 2025 | — |
| 8-K | 8-K | 0000950170-25-009227 | Jan 27, 2025 | — |
| DEF 14A | DEF 14A | 0000950170-24-134577 | Dec 9, 2024 | — |
| PRE 14A | PRE 14A | 0000950170-24-131908 | Nov 29, 2024 | — |
| 4 | 4 | 0000950170-24-131098 | Nov 26, 2024 | — |
| 4 | 4 | 0000950170-24-131093 | Nov 26, 2024 | — |
| 4 | 4 | 0000950170-24-130592 | Nov 25, 2024 | Nov 22, 2024 |
| 4 | 4 | 0000950170-24-129972 | Nov 22, 2024 | Nov 21, 2024 |
| 424B5 | 424B5 | 0000950170-24-129503 | Nov 21, 2024 | — |
| SC 13D/A | — | 0000919574-24-006855 | Nov 21, 2024 | — |
| 8-K | 8-K | 0000950170-24-129402 | Nov 20, 2024 | Nov 19, 2024 |
| 10-Q | 10-Q | 0000950170-24-127077 | Nov 14, 2024 | Sep 30, 2024 |
| 8-K | 8-K | 0000950170-24-127058 | Nov 14, 2024 | — |
| SC 13G | — | 0002012383-24-003463 | Nov 8, 2024 | — |
| SC 13G | — | 0002012383-24-001238 | Oct 22, 2024 | — |
| 4 | 4 | 0000950170-24-098731 | Aug 19, 2024 | Aug 16, 2024 |
| 8-K | 8-K | 0000950170-24-093947 | Aug 8, 2024 | — |
| 10-Q | 10-Q | 0000950170-24-094004 | Aug 8, 2024 | Jun 30, 2024 |
| 4 | 4 | 0000950170-24-081605 | Jul 3, 2024 | Jul 1, 2024 |
| 4 | 4 | 0000950170-24-081606 | Jul 3, 2024 | Jul 1, 2024 |
| 4 | 4 | 0000950170-24-081604 | Jul 3, 2024 | Jul 1, 2024 |
| 4 | 4 | 0000950170-24-081607 | Jul 3, 2024 | Jul 1, 2024 |
| 4 | — | 0000919574-24-003898 | Jul 3, 2024 | Jul 1, 2024 |
| 4 | 4 | 0000950170-24-081603 | Jul 3, 2024 | Jul 1, 2024 |
| 4 | 4 | 0000950170-24-081602 | Jul 3, 2024 | Jul 1, 2024 |
| 8-K | 8-K | 0000950170-24-073769 | Jun 14, 2024 | Jun 11, 2024 |
| 8-K | 8-K | 0000950170-24-073072 | Jun 13, 2024 | Jun 11, 2024 |
| 4 | 4 | 0000950170-24-064896 | May 28, 2024 | May 24, 2024 |
| EFFECT | — | 9999999995-24-001525 | May 14, 2024 | — |
| 8-K | 8-K | 0000950170-24-059689 | May 14, 2024 | — |
| 424B5 | 424B5 | 0000950170-24-059676 | May 14, 2024 | — |
| 8-K | 8-K | 0000950170-24-056948 | May 9, 2024 | — |
| 10-Q | 10-Q | 0000950170-24-056998 | May 9, 2024 | Mar 31, 2024 |
| DEFA14A | DEFA14A | 0000950170-24-049966 | Apr 29, 2024 | — |
| ARS | ARS | 0000950170-24-049987 | Apr 29, 2024 | — |
| DEF 14A | DEF 14A | 0000950170-24-049935 | Apr 29, 2024 | Jun 11, 2024 |
| 424B5 | — | 0001493152-24-010996 | Mar 22, 2024 | — |
| 8-K | 8-K | 0000950170-24-035365 | Mar 22, 2024 | Mar 12, 2024 |
| 4 | — | 0001493152-24-009379 | Mar 8, 2024 | Mar 7, 2024 |
| 4 | — | 0001493152-24-009384 | Mar 8, 2024 | Mar 7, 2024 |
| 4 | — | 0001493152-24-009382 | Mar 8, 2024 | Mar 7, 2024 |
| 8-K | 8-K | 0000950170-24-027951 | Mar 7, 2024 | — |
| 10-K | 10-K | 0000950170-24-027988 | Mar 7, 2024 | Dec 31, 2023 |
| S-3 | — | 0001493152-24-009248 | Mar 7, 2024 | — |
| 8-K | — | 0001493152-24-006901 | Feb 15, 2024 | Feb 14, 2024 |